Abstract:Type 2 diabetes mellitus (T2DM) is a chronic metabolic dysfunction characterized by progressive insulin resistance and hyperglycaemia. Increased blood-brain barrier (BBB) permeability is a critical neurovascular complication of T2DM that adversely affects the central nervous system homeostasis and function. Histone deacetylase 3 (HDAC3) has been reported to be elevated in T2DM animals and may promote neuroinflammation; however, its involvement in the BBB permeability of T2DM has not been investigated. In this study, we tested our hypothesis that HDAC3 expression and activity are increased in the T2DM mouse brain. Inhibition of HDAC3 may ameliorate T2DM-induced BBB permeability through Nrf2 activation. T2DM (db/db, leptin receptor-deficient), genetic non-hyperglycemic control (db/+), and wild-type male mice at the age of 16 weeks were used in this study. HDAC3 expression and activity, Nrf2 activation, and BBB permeability and junction protein expression were examined. The effects of HDAC3 activity on BBB permeability were tested using highly selective HDAC3 inhibitor RGFP966. In primary cultured human brain microvascular endothelial cells (HBMEC), hyperglycemia (25 mM glucose) plus interleukin 1 beta (20 ng/ml) (HG-IL1β) served as T2DM insult in vitro. The effects of HDAC3 on transendothelial permeability were investigated by FITC-Dextran leakage and trans-endothelial electrical resistance, and the underlying molecular mechanisms were investigated using Western blot, q-PCR, co-immunoprecipitation, and immunocytochemistry for junction protein expression, miR-200a/Keap1/Nrf2 pathway regulation. HDAC3 expression and activity were significantly increased in the hippocampus and cortex of db/db mice. Specific HDAC3 inhibition significantly ameliorated BBB permeability and junction protein downregulation in db/db mice. In cultured HBMEC, HG-IL1β insult significantly increased transendothelial permeability and reduced junction protein expression. HDAC3 inhibition significantly attenuated the transendothelial permeability and junction protein downregulation. Moreover, we demonstrated the underlying mechanism was at least in part attributed by HDAC3 inhibition-mediated miR-200a/Keap1/Nrf2 signaling pathway and downstream targeting junction protein expression in T2DM db/db mice. Our experimental results show that HDAC3 might be a new therapeutic target for BBB damage in T2DM.

NG2-Glia Cause Diabetic Blood-Brain Barrier Disruption by Secreting MMP-9

Increased blood–brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases

Glial and Vascular Cell Regulation of the Blood-Brain Barrier in Diabetes

Upregulation of C1QC as a Mediator of Blood–Brain Barrier Damage in Type 2 Diabetes Mellitus

Hyperglycemia disrupted the integrity of the blood-brain barrier following diffuse axonal injury through the sEH/NF-κB pathway

Microglia NLRP3 Inflammasomes Activation Involving Diabetic Neuroinflam-mation in Diabetic Mice and BV2 Cells

HDAC3 Inhibition Prevents Blood-Brain Barrier Permeability Through Nrf2 Activation in Type 2 Diabetes Male Mice

Impaired Blood-Brain Barrier Permeability and AD Pathogenesis in Spontaneous Type 2 Diabetic Cynomolgus Monkeys

Endothelial Neurogranin Regulates Blood–Brain Barrier Permeability via Modulation of the AKT Pathway

NG2 glia regulate brain innate immunity via TGF-β2/TGFBR2 axis

Ginkgolide B can alleviate spinal cord glymphatic system dysfunction and provide neuroprotection in painful diabetic neuropathy rats by inhibiting matrix metalloproteinase-9

Nod-Like Receptor Protein 1 Inflammasome Mediates Neuron Injury under High Glucose

Hyperglycemia Aggravates Blood–Brain Barrier Disruption Following Diffuse Axonal Injury by Increasing the Levels of Inflammatory Mediators Through the PPARγ/Caveolin-1/TLR4 Pathway

Upregulation of RAGE at the Blood‐brain Barrier in Streptozotocin‐induced Diabetic Mice

An excessive increase in glutamate contributes to glucose-toxicity in β-cells via activation of pancreatic NMDA receptors in rodent diabetes

Hyperglycemia and advanced glycation end products disrupt BBB and promote occludin and claudin-5 protein secretion on extracellular microvesicles

Blood-Brain Barrier Disruption Induced Cognitive Impairment Is Associated With Increase of Inflammatory Cytokine.

Augmented Brain Infiltration and Activation of Leukocytes after Cerebral Ischemia in Type 2 Diabetic Mice

HMGB1 plays an important role in pyroptosis induced blood brain barrier breakdown in diabetes-associated cognitive decline

An Excessive Increase In Glutamate Contributes To Glucose-Toxicity In Beta-Cells Via Activation Of Pancreatic Nmda Receptors In Rodent Diabetes

Diabetes Mellitus-Related Neurobehavioral Deficits in Mice Are Associated with Oligodendrocyte Precursor Cell Dysfunction